Sébastien Gouard

5PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 10, 2021
Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety.

Judith Anna Delage, Silvano Gnesin, John O Prior

|Jun 24, 2021
Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies.

Marion Berdal, Sébastien Gouard, Romain Eychenne

|Apr 03, 2021
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model.

Marisa Capitao, Justine Perrin, Sylvain Simon

|Sep 25, 2020
Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease.

Sébastien Gouard, Catherine Maurel, Séverine Marionneau-Lambot

|Jun 10, 2020
ImmunoPET in Multiple Myeloma-What? So What? Now What?

Clément Bailly, Benjamin Chalopin, Sébastien Gouard

Pageof 1

Frequent Collaborators

5 joint publications

Michel Chérel

2 joint publications

Clément Bailly

2 joint publications

François Guérard

2 joint publications

Nicolas Chouin